FINWIRES · TerminalLIVE
FINWIRES

SML Mahindra's May Sales Rise 15%

By

Automobile manufacturer SML Mahindra's (NSE:SMLMAH, BOM:505192) total sales rose 15% to 1,767 units in May from 1,543 units sold a year ago, according to a Monday filing to the Indian stock exchanges.

Passenger vehicle sales jumped 26% year on year in the reported month to 1,423 units, while cargo vehicle sales fell 17% to 344 units.

The company's shares were down over 2% in recent trade.

Related Articles

Asia

Xianhe's Actual Controller Fined Over Short-Swing Trading

One of Xianhe's (SHA:603733) actual controllers, Wang Minglong, received a fine of 600,000 yuan from the China Securities Regulatory Commission for short-swing trading, according to a Saturday filing on the Shanghai bourse.The Chinese packaging paper manufacturer's shares jumped 6% at the close of Monday's trade.The regulator found that Wang sold and purchased shares within six months between 2020 and 2025.

$SHA:603733
Asia

Haosen Fintech Proposes 5-for-1 Share Split

Haosen Fintech (HKG:3848) proposed a five-for-one share subdivision, according to a Friday Hong Kong bourse filing.Under the proposal, each existing share with a par value of HK$0.01 will be subdivided into five shares with a par value of HK$0.002 each.Based on the current issued share capital, the number of issued shares would increase to 782.1 million from 156.4 million.The board lot size will remain unchanged at 1,000 shares.The company said the share subdivision is expected to enhance trading liquidity, lower the investment threshold for investors, and attract broader market participation.The share subdivision is expected to take effect on July 7, subject to shareholder and regulatory approvals.

$HKG:3848
Asia

Hangzhou Bio-Sincerity Pharma-Tech's Controlling Shareholders Terminate Change-Of-Control Plans

Hangzhou Bio-Sincerity Pharma-Tech's (SHE:301096) controlling shareholders agreed to terminate the proposal to change the company's control, according to a Shenzhen bourse filing on Monday.The decision was made with related parties due to the complexity of the matter.The drug research and development company's shares slumped by less than 10% at the close.

$SHE:301096